Skip to content
10-Q

Quarterly Report

Gritstone bio, Inc.

0000950170-24-056964

← back to feed
Filed
May 9, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 6, 2024 108.57M sh
Shares Diluted Q1 2024 · Mar 31, 2024 118.39M sh
Shares Diluted Q1 2024 · Mar 31, 2023 114.42M sh
Capex Q1 2024 · Mar 31, 2024 $143K
Capex Q1 2024 · Mar 31, 2023 $1.57M
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$33.57M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$40.09M
Long Term Debt Q1 2024 · Mar 31, 2024 $40.33M
Long Term Debt Q1 2024 · Dec 31, 2023 $40.14M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $42.4M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $62.99M
Stockholders Equity Q1 2024 · Mar 31, 2024 $13.96M
Stockholders Equity Q1 2024 · Dec 31, 2023 $51.85M
Stockholders Equity Q1 2024 · Mar 31, 2023 $140.88M
Stockholders Equity Q1 2024 · Dec 31, 2022 $170.78M
Current Liabilities Q1 2024 · Mar 31, 2024 $25.87M
Current Liabilities Q1 2024 · Dec 31, 2023 $27.34M
Total Liabilities Q1 2024 · Mar 31, 2024 $123.25M
Total Liabilities Q1 2024 · Dec 31, 2023 $125.92M
Current Assets Q1 2024 · Mar 31, 2024 $51.85M
Current Assets Q1 2024 · Dec 31, 2023 $87.44M
Total Assets Q1 2024 · Mar 31, 2024 $137.21M
Total Assets Q1 2024 · Dec 31, 2023 $177.77M
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.34
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.30
Eps Basic Q1 2024 · Mar 31, 2024 −$0.34
Eps Basic Q1 2024 · Mar 31, 2023 −$0.30
Sga Expense Q1 2024 · Mar 31, 2024 $8.5M
Sga Expense Q1 2024 · Mar 31, 2023 $6.75M
Rd Expense Q1 2024 · Mar 31, 2024 $33.04M
Rd Expense Q1 2024 · Mar 31, 2023 $30.51M
Net Income Q1 2024 · Mar 31, 2024 −$40.39M
Net Income Q1 2024 · Mar 31, 2023 −$33.98M
Operating Income Q1 2024 · Mar 31, 2024 −$39.8M
Operating Income Q1 2024 · Mar 31, 2023 −$34.82M
Revenue Q1 2024 · Mar 31, 2024 $1.74M
Revenue Q1 2024 · Mar 31, 2023 $2.44M